- Home
- ALEC vs GRX Comparison
ALEC vs GRX Comparison
Compare ALEC & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALEC
- GRX
- Stock Information
- Founded
- ALEC 2013
- GRX 2007
- Country
- ALEC United States
- GRX United States
- Employees
- ALEC N/A
- GRX N/A
- Industry
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- GRX Finance/Investors Services
- Sector
- ALEC Health Care
- GRX Finance
- Exchange
- ALEC Nasdaq
- GRX Nasdaq
- Market Cap
- ALEC 124.0M
- GRX 145.5M
- IPO Year
- ALEC 2019
- GRX N/A
- Fundamental
- Price
- ALEC $2.95
- GRX $9.17
- Analyst Decision
- ALEC Buy
- GRX
- Analyst Count
- ALEC 8
- GRX 0
- Target Price
- ALEC $4.50
- GRX N/A
- AVG Volume (30 Days)
- ALEC 1.2M
- GRX 39.7K
- Earning Date
- ALEC 11-05-2025
- GRX 01-01-0001
- Dividend Yield
- ALEC N/A
- GRX 5.98%
- EPS Growth
- ALEC N/A
- GRX N/A
- EPS
- ALEC N/A
- GRX 0.26
- Revenue
- ALEC $81,130,000.00
- GRX N/A
- Revenue This Year
- ALEC N/A
- GRX N/A
- Revenue Next Year
- ALEC $196.86
- GRX N/A
- P/E Ratio
- ALEC N/A
- GRX $38.50
- Revenue Growth
- ALEC 46.77
- GRX N/A
- 52 Week Low
- ALEC $0.87
- GRX $7.73
- 52 Week High
- ALEC $6.37
- GRX $10.40
- Technical
- Relative Strength Index (RSI)
- ALEC 62.76
- GRX 35.32
- Support Level
- ALEC $2.71
- GRX $9.33
- Resistance Level
- ALEC $3.00
- GRX $9.56
- Average True Range (ATR)
- ALEC 0.22
- GRX 0.08
- MACD
- ALEC -0.01
- GRX -0.04
- Stochastic Oscillator
- ALEC 74.29
- GRX 8.14
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.